You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

51 Results
Drug
Other Name(s): Xeloda®
Jul 2024
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Adjuvant, Palliative
Aug 2017
Regimen
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Adjuvant, Palliative
Funding:
ODB - General Benefit
    capecitabine
Jul 2024
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Intent: Adjuvant
Oct 2017
Regimen
Regimen
Intent: Palliative, Adjuvant
Nov 2017

Pages